Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant

NCT01559844 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C
Hepatocellular Carcinoma

Interventions

DRUG: Sofosbuvir
DRUG: Ribavirin

Sponsor

Gilead Sciences